Institute of Medical Biology, Chinese Academy of Medical Sciences
29
2
3
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 29 trials
100.0%
+13.5% vs industry average
52%
15 trials in Phase 3/4
0%
0 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (29)
Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine
Role: lead
Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine
Role: lead
Study on the Persistence of Immunity Following EV71 Vaccination
Role: lead
Study of Concomitant Administration of the sIPV and DTaP or MMR
Role: lead
Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
Role: lead
Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
Role: lead
Phase IV Study of Concomitant Administration of the sIPV and HepA
Role: lead
Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
Role: collaborator
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
Role: lead
Phase II Clinical Trial of the Inactivated Rotavirus Vaccine
Role: lead
Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine
Role: lead
A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants
Role: lead
A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
Role: lead
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)
Role: lead
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19
Role: lead
Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11
Role: lead
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)
Role: lead
Inactivated Poliomyelitis Vaccine Made From Sabin Strain
Role: lead
Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV
Role: lead
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years
Role: lead